Please wait a minute...
 Home  Journals Subscription Open Access About Us
中文
 
Just Accepted  |  Online First  |  Current Issue  |  Archive  |  Special Issues  |  Featured Articles  |  Most Downloaded
Journal of Translational Neuroscience    2019, Vol. 4 Issue (1) : 38-49     https://doi.org/10.3868/j. issn. 2096-0689. 2019. 01. 004
Review
New advances in multiple system atrophy
Lingyu Zhang, Bei Cao, Huifang Shang*
Department of Neurology, West China Hospital, Sichuan University, Chengdu 610041, China
Download: PDF(14376 KB)  
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract Multiple system atrophy (MSA) is a rapidly progressive neurodegenerative disorder characterized by a variable combination of autonomic failure, parkinsonism with poor response to levodopa, cerebellar ataxia and pyramidal symptoms. The pathological hallmark of MSA is the oligodendrocytic glial cytoplasmic inclusions (GCIs) consisting of α-synuclein, and so MSA, together with Parkinson’s disease (PD) and dementia with Lewy bodies (DLB), is an α-synucleinopathy. Currently few effective biomarkers have been identified for the diagnosis or prognosis of MSA, and there is no established therapy to delay its progression. In this review, we discuss the epidemiology, neuropathology, genetics, clinical presentation and diagnostic biomarkers of MSA, as well as recent advances in its treatment.
Keywords multiple system atrophy (MSA)      neurodegenerative disorder     
Issue Date: 25 March 2019
 Cite this article:   
Lingyu Zhang, Bei Cao, Huifang Shang. New advances in multiple system atrophy[J]. Journal of Translational Neuroscience,2019, 4(1): 38-49.
 URL:  
http://journal.hep.com.cn/jtn/EN/10.3868/j. issn. 2096-0689. 2019. 01. 004
http://journal.hep.com.cn/jtn/EN/Y2019/V4/I1/38
Service
E-mail this article
E-mail Alert
RSS
Articles by authors
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
Copyright © 2014 Higher Education Press, All Rights Reserved. Powered by Beijing Magtech Co. Ltd
Service: 010-58556313 (Technology); 010-58556485 (Subscription) E-mail: subscribe@hep.com.cn